FIELD: pharmaceuticals.
SUBSTANCE: product for treating of tumor cachexia, which is a dry extract of the leaves and blossoms of gratiola officinalis obtained by pulverizing them alcohol extraction of 96% in a water bath to boiling and evaporation, dilution of the evaporated residue first with distilled water and then adding chloroform, cooled to room temperature and centrifugation, followed by separating an aqueous fraction and drying it under certain conditions.
EFFECT: exemplified agent is effective for the prophylaxis and treatment of tumoral cachexia.
1 cl, 1 tbl, 1 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING ANTI-CACHEXIC, ANTI-TUMOUR PROPERTIES AND REDUCING ENDOGENOUS INTOXICATION LEVEL | 2015 |
|
RU2601406C1 |
| AGENT CAUSING IN VIVO EXPERIMENTS IN SUBSTITUTION OF TUMOR CONNECTIVE TISSUE AND TRANSFERRING TUMOR CELLS FROM G1 PHASE OF CELL CYCLE INTO REST STATE G0 | 2018 |
|
RU2731105C2 |
| METHOD OF COMBINED LIVER CANCER PC-1 THERAPY IN EXPERIMENT | 2020 |
|
RU2734143C1 |
| AGENT POSSESSING ANTINEOPLASTIC AND IMMUNOMODULATORY ACTION | 2013 |
|
RU2519769C1 |
| AGENT HAVING SELECTIVE ACTION ON TUMOR CELLS, ACTIVATING APOPTOSIS THEREOF AND PREVENTING FORMATION OF RESISTANCE THEREOF | 2018 |
|
RU2694547C1 |
| METHOD FOR DETERMINING MINIMUM EFFECTIVE CONCENTRATION OF ANTITUMOUR DRUG WHICH INHIBITS CYTOPROTECTIVE AUTOPHAGY IN VITRO | 2018 |
|
RU2693829C1 |
| ANTITUMOR AGENT | 1998 |
|
RU2145854C1 |
| AGENT EXHIBITING WOUND HEALING ACTIVITY | 2018 |
|
RU2714930C2 |
| MEDICINAL PREPARATION POSSESSING ANTITUMOR ACTIVITY | 1988 |
|
RU2039560C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY, ANTIPYRETIC AND ANTIMICROBIAL ACTION | 2013 |
|
RU2535155C1 |
